当前位置:首页 - 行情中心 - 圣诺生物(688117) - 财务分析 - 现金流量表

圣诺生物

(688117)

  

流通市值:52.73亿  总市值:52.73亿
流通股本:2.20亿   总股本:2.20亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金463,218,569.87181,689,556.36733,108,680.57493,707,682.87
  收到的税费返还22,798,915.1214,399,691.5520,151,491.2917,075,334.49
  收到其他与经营活动有关的现金6,435,355.257,813,167.5272,990,764.7442,804,558.95
  经营活动现金流入小计492,452,840.24203,902,415.43826,250,936.6553,587,576.31
  购买商品、接受劳务支付的现金203,500,284.64118,622,388.9314,497,155.77251,633,096.52
  支付给职工以及为职工支付的现金98,121,168.5253,510,049151,084,783.43114,208,566.35
  支付的各项税费31,459,360.7511,800,823.1731,595,015.3526,330,978.42
  支付其他与经营活动有关的现金72,146,356.8542,093,123.61150,627,985.07101,312,829.81
  经营活动现金流出小计405,227,170.76226,026,384.68647,804,939.62493,485,471.1
  经营活动产生的现金流量净额87,225,669.48-22,123,969.25178,445,996.9860,102,105.21
二、投资活动产生的现金流量:
  收回投资收到的现金--19,079,369.2329,621,311.08
  取得投资收益收到的现金314,240.1664,791.91526,802.08338,726.96
  处置固定资产、无形资产和其他长期资产收回的现金净额--97,545.33-
  处置子公司及其他营业单位收到的现金净额--1,659,467.04-
  收到的其他与投资活动有关的现金176,000,00026,000,000122,670,00065,000,000
  投资活动现金流入小计176,314,240.1626,064,791.91144,033,183.6894,960,038.04
  购建固定资产、无形资产和其他长期资产支付的现金53,501,326.9831,471,266.65145,766,800.4999,910,716.99
  投资支付的现金10,500,00010,500,00066,000,00070,670,000
  支付其他与投资活动有关的现金240,000,00090,000,000122,670,000112,160,532.96
  投资活动现金流出小计304,001,326.98131,971,266.65334,436,800.49282,741,249.95
  投资活动产生的现金流量净额-127,687,086.82-105,906,474.74-190,403,616.81-187,781,211.91
三、筹资活动产生的现金流量:
  取得借款收到的现金341,000,000168,000,000437,905,460.82301,405,460.82
  收到其他与筹资活动有关的现金--89,080,000110,000,000
  筹资活动现金流入小计341,000,000168,000,000526,985,460.82411,405,460.82
  偿还债务支付的现金208,857,51098,300,000413,030,000238,730,000
  分配股利、利润或偿付利息支付的现金60,867,141.454,905,968.5935,995,105.2526,643,208.25
  支付其他与筹资活动有关的现金43,800,181.996,926,221.4417,633,878.09-
  筹资活动现金流出小计313,524,833.44110,132,190.03466,658,983.34265,373,208.25
  筹资活动产生的现金流量净额27,475,166.5657,867,809.9760,326,477.48146,032,252.57
四、汇率变动对现金及现金等价物的影响-1,807,014.64-737,838.6-762,029.61-905,097.76
五、现金及现金等价物净增加额-14,793,265.42-70,900,472.6247,606,828.0417,448,048.11
  加:期初现金及现金等价物余额253,089,602.1281,052,370.34205,482,774.06205,482,774.06
  期末现金及现金等价物余额238,296,336.68210,151,897.72253,089,602.1222,930,822.17
补充资料:
  净利润135,194,010.21-157,889,937.35-
  资产减值准备5,858,242.39-14,873,082.1-
  固定资产和投资性房地产折旧36,740,100.56-54,575,666.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧36,740,100.56-54,575,666.79-
  无形资产摊销1,133,651.04-1,961,618.88-
  长期待摊费用摊销813,959.4-1,473,356.74-
  固定资产报废损失120,233.95-1,531,851.71-
  公允价值变动损失---248,900-
  财务费用10,446,822.48-18,296,093.44-
  投资损失-31,808.5--1,955,306.77-
  递延所得税1,361,610.72--3,486,480.29-
  其中:递延所得税资产减少1,361,610.72--3,486,480.29-
  存货的减少-61,241,368.71--51,208,484.52-
  经营性应收项目的减少-16,127,460.17--79,137,548.66-
  经营性应付项目的增加-27,729,880.36-57,316,359.92-
  其他--2,803,520.27-
  现金的期末余额238,296,336.68-253,089,602.1-
  减:现金的期初余额253,089,602.1-205,482,774.06-
  现金及现金等价物的净增加额-14,793,265.42-47,606,828.04-
公告日期2026-08-202026-04-242026-04-242025-10-28
审计意见(境内)标准无保留意见
TOP↑